针刺配合药物治疗肝郁脾虚型反流性咽喉炎的疗效观察

来源 :针灸推拿医学(英文版) | 被引量 : 0次 | 上传用户:fanfansis
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:观察针刺配合药物治疗肝郁脾虚型反流性咽喉炎的临床疗效.方法:将70例患者按随机数字表法分为对照组和观察组,每组35例.两组均接受常规药物治疗,观察组另外加用针刺治疗.评定反流症状指数(RSI)、反流体征评分(RFS),测定食管下括约肌压力(LESP)、食管上括约肌压力(UESP)等食管动力指标及唾液胃蛋白酶水平,比较两组临床疗效.结果:观察组有效率高于对照组(P<0.05);治疗后,两组RSI及RFS评分均显著降低(均P<0.05),观察组RSI及RFS评分均显著低于对照组(均P0.05),观察组LESP及UESP显著增高(均P<0.05),且高于对照组(均P<0.05);两组唾液胃蛋白酶水平均降低(均P<0.05),观察组唾液胃蛋白酶水平显著低于对照组(P<0.05).结论:针刺配合药物治疗肝郁脾虚型反流性咽喉炎可改善患者症状及体征,调节食管动力及唾液胃蛋白酶水平,其疗效优于单独药物治疗.“,”Objective: To observe the clinical efficacy of acupuncture plus medicine in treating laryngopharyngeal reflux due to liver-qi stagnation and spleen deficiency. Methods: A total of 70 patients were divided into a control group and an observation group by the random number table method, with 35 cases in each group. Both groups were treated with conventional medications, and the observation group was treated with additional acupuncture therapy. The reflux symptom index (RSI) and reflux finding score (RFS) were evaluated. Esophageal motility indicators such as lower esophageal sphincter pressure (LESP) and upper esophageal sphincter pressure (UESP), and salivary pepsin level were measured. The clinical efficacy was also compared. Results: The total effective rate of the observation group was higher than that of the control group (P<0.05). After treatment, the RSI and RFS scores in both groups decreased significantly (all P<0.05), and the RSI and RFS scores in the observation group were significantly lower than those in the control group (both P0.05), while LESP and UESP in the observation group increased significantly (both P<0.05), and higher than those in the control group (both P<0.05). The salivary pepsin levels in both groups decreased (both P<0.05), and the salivary pepsin level in the observation group was significantly lower than that in the control group (P<0.05). Conclusion: Acupuncture plus medicine can improve symptoms and signs in patients with laryngopharyngeal reflux due to liver-qi stagnation and spleen deficiency, and regulate esophageal motility and salivary pepsin level. Its efficacy is more significant compared with medicine alone.
其他文献
[關键词] 乙型肝炎;病毒复制;肝纤维化五项;肝硬化  [中图分类号] R436 [文献标识码] B [文章编号] 1673-9701(2021)14-0135-04  Clinical application of combined detection of viral replication and five items of liver fibrosis in patient
[摘要] 目的 探讨在微创通道下减压结合经皮椎弓根螺钉复位内固定治疗伴有神经根损伤的胸腰椎骨折疗效。方法 选取2019年6月至2020年6月于本院就诊的胸腰椎骨折伴神经根损伤患者60例,按照单双日分成A组与B组,每组各30例。A组予以传统开放椎弓根螺钉复位内固定治疗,B组在微创通道下减压结合经皮椎弓根螺钉复位内固定治疗。并比较治疗前后伤椎Cobb角,伤椎椎体前缘高度比值变化,术后疼痛程度及相关手术
[关键词] 脊髓型颈椎病;非手术;外科手术;手术方式;研究进展  [中图分类号] R681.55 [文献标识码] A [文章编号] 1673-9701(2021)14-0189-04  Progress in treatment of cervical spondylotic myelopathy  ZENG Guangwu  Department of Orthopedics,G
[关键词] 神经外科;肠内营养;鼻饲;误吸;预防护理  [中图分类号] R473.6 [文献标识码] B [文章编号] 1673-9701(2021)14-0178-04  Analysis on the causes of aspiration and nursing measures in the patients with neurosurgical coma during
[关键词] 互联网 ;延续护理;PFNA;Harris评分;改良Barthel指数  [中图分类号] R473.6 [文献标识码] B [文章编号] 1673-9701(2021)14-0185-04  Research on the application of internet plus transitional care after PFNA operation  GUO L
[關键词] 肺结核;菌阴;体层摄影术;X线计算机  [中图分类号] R445.3 [文献标识码] B [文章编号] 1673-9701(2021)14-0123-04  Analysis of the MSCT manifestations of 59 cases of initially treated active pulmonary tuberculosis with bac
[關键词] 宫颈癌;放射治疗;照射剂量;治疗靶区;影像学技术  [中图分类号] R737.33 [文献标识码] B [文章编号] 1673-9701(2021)14-0095-04  Study on the correlation between imaging and pathology of cervical cancer radiotherapy target area  
[关键词] 胸部X线;CT;小儿肺炎支原體肺炎;准确率;可见症状  [中图分类号] R725.6 [文献标识码] B [文章编号] 1673-9701(2021)14-0127-04  Comparison of clinical effectiveness of chest X-ray and CT in diagnosis of mycoplasma pneumonia in
[關键词] 颈性眩晕;葛根汤;针灸;临床疗效  [中图分类号] R255.3 [文献标识码] B [文章编号] 1673-9701(2021)14-0151-04  Clinical efficacy of Modified Puerariae Decoction combined with acupuncture and moxibustion on patients with
[关键词] 2型糖尿病;卵巢综合征;利拉鲁肽;降浊合剂  [中图分类号] R711.75 [文献标识码] B [文章编号] 1673-9701(2021)14-0142-05  Clinical effect of Jiangzhuo Mixture combined with liraglutide in the treatment of type 2 diabetes with